be_ixf;ym_202604 d_19; ct_50
NASDAQ:OGI charts & data provided by TradingView

Latest Insights on OGI

We asked you for DoorDash opinions, and boy, we got ‘em! Get the latest on the DoorDash IPO — and if should buy in when DASH goes public. DoorDash Rehash; I’m With the BAND; Uber’s Robo-Taxi No More November 19, 2020 by Joseph Hargett Great Stuff Knocking on Heaven’s Door(Dash) Great Ones … welcome to Reader Feedback day! If you happen to be new ‘round these parts, today’s the day that Great Stuff answers your questions, researches your investment ideas and indulges in your rants … whatever the topic may be. Seriously. Last week, we covered everything from artificial intelligence to […]
The DoorDash IPO Is Doomed … but You Can Profit From It November 17, 2020 by Ted Bauman Big Picture. Big Profits., Investing, Stocks, Trading Strategies [4-minute read] Here’s how to make gains on a company with no prospects.
Can you be too cool for the vaccine race? As it turns out, yes you can! With Moderna’s vaccine coming in hot, Pfizer just got one-upped. Pfizer Pforfeit; A Nio Dealio; Uber’s Hail Mary November 16, 2020 by Joseph Hargett Great Stuff Born to Run In the day, we sweat it out on Wall Street. It’s a runaway American dream. At night, we’re locked in mansions of glory, no more suicide machines. But all that might be about to change… Sprung from Phase 3 on highway nine, Moderna’s new injection is stepping out over the line. (Woah!) […]
new normal companies to invest in New COVID-19 Technologies Are Here to Stay November 16, 2020 by Ian King Technology, Winning Investor Daily Although the coronavirus might be a thing of the past by this time next year, technology’s gains are here to stay…
The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it. COVID-19 Vaccine Firm Soars 650% — Huge Opportunities Ahead November 14, 2020 by Jay Goldberg Investment Opportunities, Winning Investor Daily The effectiveness of the COVID-19 vaccine is remarkable. But what’s even more remarkable is that a relatively small firm played such a large role in developing it.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

“Looks like I have finally found the right person to learn and grow from.”

- James

"Since I started following your secret over your multiple publications, my $659,000 account is up to $715,000 in just 2 months. I’m up $56,000 in one month alone."

- Will O.

Share This